Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - CAPITAL EXPENDITURES
Capital Expenditures IMVT - Immunovant, Inc.
-360 K
LAST VALUE
-19.05%
2 YEAR CAGR
-47.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR